| Product Name | MF | CAS | Details |
|---|
| PD184161 | C17H13BrClF2IN2O2 | 212631-67-9 | Details |
| Fustin | C15H12O6 | 20725-03-5 | Details |
| L-Moses | C21H24N6 | 2079885-05-3 | Details |
| KEA1-97 | C15H9Cl2FN4 | 2138882-71-8 | Details |
| HTH-01-091 | C26H28Cl2N4O2 | 2000209-42-5 | Details |
| AP1867-3-(aminoethoxy) | C38H50N2O9 | 2127390-15-0 | Details |
| CA inhibitor 1 | C41H36ClF8N7O5S2 | 2189684-45-3 | Details |
| PKUMDL-LC-101-D04 | C14H23ClN4O2S2 | 2143896-83-5 | Details |
| Eclitasertib | C19H18N6O3 | 2125450-76-0 | Details |
| Capsiate | C18H26O4 | 205687-01-0 | Details |
| BMS 753 | C21H21NO4 | 215307-86-1 | Details |
| PDGFR Tyrosine Kinase Inhibitor III | C27H27N5O4 | 205254-94-0 | Details |
| AZ13705339 hemihydrate | C33H36FN7O3S | 2016806-57-6 | Details |
| SMYD3-IN-1 | C28H31ClN4O3 | 2095160-79-3 | Details |
| RAD51-IN-1 | C22H16ClN3O | 2101739-18-6 | Details |
| IACS-13909 | C17H18Cl2N6 | 2160546-07-4 | Details |
| Bocidelpar | C25H27F3N2O3 | 2095128-20-2 | Details |
| RORγt inverse agonist 13 | C23H17Cl2F3N2O4 | 2170477-75-3 | Details |
| Enpatoran | C16H15F3N4 | 2101938-42-3 | Details |
| LY392098 | C18H22FNO2S | 211311-39-6 | Details |
| SGC-SMARCA-BRDVIII | C19H25N5O3 | 1997319-84-2 | Details |
| Enpatoran hydrochloride | C16H16ClF3N4 | 2101945-93-9 | Details |
| GNE-064 | C17H21N5O2 | 1997321-20-6 | Details |
| Edaglitazone | C24H20N2O4S2 | 213411-83-7 | Details |
| Laninamivir octanoate | C21H36N4O8 | 203120-46-1 | Details |
| MS-PPOH | C16H21NO4S | 206052-02-0 | Details |
| SB-273005 | C22H24F3N3O4 | 205678-31-5 | Details |
| 2'-O-Methylguanosine | C11H15N5O5 | 2140-71-8 | Details |
| GSK8814 | C28H35F2N5O3 | 1997369-78-4 | Details |
| LTβR-IN-1 | C18H16N4O2 | 2189366-77-4 | Details |
| Rilmenidine phosphate | C12H12ClN3 | 205437-64-5 | Details |
| 2BAct | C19H16ClF3N4O3 | 2143542-28-1 | Details |
| Parsaclisib hydrochloride | C20H23Cl2FN6O2 | 1995889-48-9 | Details |
| TP-021 | C20H20ClN3O5 | 2130878-25-8 | Details |
| Cedirogant | C24H20Cl3F3N2O3 | 2055496-11-0 | Details |
| MAGL-IN-4 | C18H21ClN2O4 | 2135785-20-3 | Details |
| GSK-3685032 | C22H24N6OS | 2170137-61-6 | Details |
| Rimtuzalcap | C18H24F2N6O | 2167246-24-2 | Details |
| FASN-IN-3 | C24H24N4O | 2097262-60-5 | Details |
| Atuliflapon | C24H26N6O3 | 2041075-86-7 | Details |
| PHD-1-IN-1 | C13 H8 N4 | 2009343-14-8 | Details |
| PPOH | C15H18O3 | 206052-01-9 | Details |
| ASN007 | C22H25ClFN7O2 | 2055597-12-9 | Details |
| Secnidazole-d | C11H9FO3 | 2114651-20-4 | Details |
| Pirtobrutinib | C22H21F4N5O3 | 2101700-15-4 | Details |
| NHWD-870 | C29H29N7O | 2115742-03-3 | Details |
| Vociprotafib | C20H27ClN6O2S | 2172652-48-9 | Details |
| α5IA | C17H14N8O2 | 215874-86-5 | Details |
| NSC 617145 | C13H10Cl4N2O4 | 203115-63-3 | Details |
| RIP1 kinase inhibitor 1 | C24H20ClN5O3 | 2095515-38-9 | Details |
| Spiraeoside | C21H20O12 | 20229-56-5 | Details |
| Lisaftoclax | C45H48ClN7O8S | 2180923-05-9 | Details |
| (Rac)-X77 | C27H33N5O2 | 2144491-78-9 | Details |
| GSK620 | C18H19N3O3 | 2088410-46-0 | Details |
| Cevidoplenib dimesylate | C26H31N7O6S | 2043659-93-2 | Details |
| FLT3-IN-10 | C15H11FN2O | 2088735-51-5 | Details |
| BIRT 377 | C18H15BrCl2N2O2 | 213211-10-0 | Details |
| AOH1160 | C25H20N2O3 | 2089314-57-6 | Details |
| Diprovocim | C56H56N6O6 | 2170867-89-5 | Details |
| PXS-5120A | C22H25ClFN3O4S | 2125955-70-4 | Details |
| VTP50469 fumarate | C36H51FN6O8S | 2169919-29-1 | Details |
| HCV-IN-31 | C12H17FN6O3 | 1998705-62-6 | Details |
| Picroside IV | C24H28O12 | 211567-04-3 | Details |
| 2′,7′-Dichlorofluorescein diacetate | C24H14Cl2O7 | 2044-85-1 | Details |
| ALX-5407 hydrochloride | C24H25ClFNO3 | 200006-08-2 | Details |
| TRAM-39 | C20H14ClN | 197525-99-8 | Details |
| P-gp inhibitor 1 | C32H31N5O2 | 2050747-49-2 | Details |
| MLT-747 | C20H21Cl2N7O3 | 2097853-86-4 | Details |
| SERCA2a activator 1 | C32H29N3O4S | 2139330-34-8 | Details |
| Reuterin | C3H6O2 | 2134-29-4 | Details |
| Et-29 | C34H46N6O6S | 2166487-23-4 | Details |
| NLG802 | C20H30ClN3O3 | 2071683-99-1 | Details |
| Imatinib-d | C23H25N5O4S | 205256-55-9 | Details |
| Gly-Phe-β-naphthylamide | C21H21N3O2 | 21438-66-4 | Details |
| Teduglutide | C164H252N44O55S | 197922-42-2 | Details |
| Ro 3-1314 | C18H28O2 | 2012-14-8 | Details |
| JNJ-55308942 | C17H12F5N7O | 2166558-11-6 | Details |
| SHP394 | C20H25F3N6O2S | 2055757-40-7 | Details |
| ENMD-1198 | C28H26N2O12P2 | 2097938-74-2 | Details |
| NV-5138 | C7H13F2NO2 | 2095886-80-7 | Details |
| TRPM8 antagonist 3 | C13H12N2O4S | 2102179-29-1 | Details |
| Inarigivir ammonium | C20H29N8O10PS | 2172788-92-8 | Details |
| 4-PPBP maleate | C25H31NO4 | 201216-39-9 | Details |
| OBI-3424 | C21H25N4O6P | 2097713-68-1 | Details |
| SRI-29329 | C20H26ClN7 | 2086809-58-5 | Details |
| Bemnifosbuvir | C24H33FN7O7P | 1998705-64-8 | Details |
| ML-211 | C25H30N4O2 | 2205032-89-7 | Details |
| Oritinib | C31H37N7O2 | 2035089-28-0 | Details |
| Glycine-2- | C2H5NO2 | 20220-62-6 | Details |
| Methylene blue hydrate | C6H15ClN4O2 | 201740-91-2 | Details |
| Vebicorvir | C19H12F3N3O4S2 | 2090064-66-5 | Details |
| BMS-1166 hydrochloride | C36H34Cl2N2O7 | 2113650-05-6 | Details |
| USP30 inhibitor 11 | C17H16N6O2S | 2067332-64-1 | Details |
| GENZ-882706 | C26H25N5O3 | 2070864-35-4 | Details |
| AT-130 | C22H22BrN3O5 | 211364-06-6 | Details |
| KDM2A/7A-IN-1 | C33H38N4O | 2169272-46-0 | Details |
| S18-000003 | C26H25F3N2O4S | 2068119-11-7 | Details |
| Fanotaprim | C19H22N8O | 2120282-75-7 | Details |
| Vepafestinib | C26H30N6O3 | 2129515-96-2 | Details |
| Tovinontrine | C21H26N6O2 | 2062661-53-2 | Details |
| Product Total： Product Page： | ||||
| 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 | ||||